FrieslandCampina Ingredients and Triplebar Bio partner on cell-based proteins
Image: FrieslandCampina Ingredients
FrieslandCampina Ingredients has entered a strategic partnership with specialist biotechnology company Triplebar Bio to develop and scale up the production of cell-based proteins using precision fermentation. This latest partnership follows the company’s launch of its first plant protein range, Plantaris, in partnership with AGT Foods in November 2021.
California-based biotechnology company, Triplebar, specialises in bioengineering at speed to develop solutions for the nutrition and healthcare industries. FrieslandCampina Ingredients and Triplebar will produce microbial cells through precision fermentation that can create bioactive proteins that support human health and nutrition in early life and adulthood. The ambition of both companies is to manufacture high quality proteins for various applications at scale and with a limited land, water and energy footprint. FrieslandCampina Ingredients has been using precision fermentation since 2016 to produce human milk oligosaccharides (HMOs). The company will leverage its unique combination of protein experience alongside its innovation, processing and technical expertise to produce highly nutritious, alternative protein solutions using the latest precision fermentation technology.
“Precision fermentation is a fast-developing technology that will shape the future of the food and nutrition industry,” said Anne Peter Lindeboom, managing director Innovation at FrieslandCampina Ingredients. “Dairy ingredients will continue to play a vital role in the future of nutrition as a source of high-quality proteins and prebiotics and these remain our core offering. At the same time, we are continuously exploring new ways that technology and nature can be harnessed to support consumers with special dietary needs – at every stage of life.”